Haleon PLC — Investor Relations & Filings
Haleon PLC is a global consumer healthcare company focused on improving everyday health. The company develops and markets a portfolio of category-leading brands built on scientific innovation and trusted by consumers and healthcare professionals. Its product offerings span several key categories, including Oral Health, Pain Relief, Respiratory Health, and Vitamins, Minerals, and Supplements. Notable brands within its portfolio include Sensodyne, Advil, Voltaren, and Centrum. Haleon's mission is to deliver better everyday health with humanity, making it more achievable, inclusive, and sustainable.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Director/PDMR Shareholding | 2026-05-22 | English | |
| DIRECTOR/PDMR SHAREHOLDING | 2026-05-22 | English | |
| Director/PDMR Shareholding | 2026-05-18 | English | |
| DIRECTOR/PDMR SHAREHOLDING | 2026-05-18 | English | |
| TRANSACTIONS IN OWN SHARES | 2026-05-18 | English | |
| Transactions in Own Shares | 2026-05-18 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46816131 | Director/PDMR Shareholding | 2026-05-22 | English | ||
| 46832398 | DIRECTOR/PDMR SHAREHOLDING | 2026-05-22 | English | ||
| 46386007 | Director/PDMR Shareholding | 2026-05-18 | English | ||
| 46403889 | DIRECTOR/PDMR SHAREHOLDING | 2026-05-18 | English | ||
| 46384355 | TRANSACTIONS IN OWN SHARES | 2026-05-18 | English | ||
| 46381152 | Transactions in Own Shares | 2026-05-18 | English | ||
| 44935763 | 6-K - Haleon plc (0001900304) (Filer) | 2026-05-11 | English | ||
| 44893542 | Transactions in Own Shares | 2026-05-11 | English | ||
| 43261534 | 6-K - Haleon plc (0001900304) (Filer) | 2026-05-07 | English | ||
| 43164763 | EMTN programme publication of listing particulars | 2026-05-07 | English | ||
| 41342774 | 6-K - Haleon plc (0001900304) (Filer) | 2026-05-05 | English | ||
| 41263024 | Transactions in Own Shares | 2026-05-05 | English | ||
| 39563495 | 6-K - Haleon plc (0001900304) (Filer) | 2026-05-01 | English | ||
| 39537301 | Total Voting Rights and Capital | 2026-05-01 | English | ||
| 38696493 | 6-K - Haleon plc (0001900304) (Filer) | 2026-04-29 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for Haleon PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
Haleon PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/5111/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=5111 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=5111 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=5111 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 5111}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Haleon PLC (id: 5111)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.